Logo-jcvtr

J Cardiovasc Thorac Res. 2014;6(3): 191-195. doi: 10.15171/jcvtr.2014.010
PMID: 25320668        PMCID: PMC4195971

Original Article

Mitral Valve Restenosis after Percutaneous Transmitral Valvuloplasty, Role of Continuous Inflammation

Mohammadali Ostovan 1 * , Amir Aslani 1, Shahima Abounajmi 1, Vida Razazi 2

Cited by CrossRef: 3


1- Mechmeche R, Zaroui A, Aloui S, Boukhris M, Allal-Elasmi M, Kaabachi N, Zouari B. Late mitral restenosis after percutaneous commissurotomy: Predictive value of inflammation and extracellular matrix remodeling biomarkers. Heart & Lung. 2017;46(4):258 [Crossref]
2- Separham A, Pourafkari L, Bodagh H, Ghaffari S, Aslanabadi N, Nader N. Predicting outcome after percutaneous balloon mitral commissurotomy. Herz. 2017;42(5):509 [Crossref]
3- Mengie A, Admassu E, Habtamu D, Berhie A, Mulatu K, Lidetu T. Prevalence and associated factors of atrial fibrillation among patients with rheumatic heart disease attending public referral hospitals in Bahir Dar city, Northwest Ethiopia, 2023. BMC Cardiovasc Disord. 2024;24(1) [Crossref]
4- Noubiap J, Nyaga U, Ndoadoumgue A, Nkeck J, Ngouo A, Bigna J. Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease. 2020;15(1) [Crossref]